These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2854216)

  • 1. Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.
    Siegl PK; Garcia ML; King VF; Scott AL; Morgan G; Kaczorowski GJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):684-91. PubMed ID: 2854216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
    Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.
    King VF; Garcia ML; Himmel D; Reuben JP; Lam YK; Pan JX; Han GQ; Kaczorowski GJ
    J Biol Chem; 1988 Feb; 263(5):2238-44. PubMed ID: 2448307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the cardiotonic agent DPI 201-106 with cardiac Ca2+ channels.
    Holck M; Osterrieder W
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):478-82. PubMed ID: 2453753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations of the mechanism of the positive inotropic action of BDF 9148: comparison with DPI 201-106 and the enantiomers.
    Raap A; Armah B; Mest HJ; Stenzel W; Schloos J; Blechacz W
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):164-73. PubMed ID: 9057064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.
    Scholtysik G; Salzmann R; Berthold R; Herzig JW; Quast U; Markstein R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):316-25. PubMed ID: 2991779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative.
    Armah BI; Pfeifer T; Ravens U
    Br J Pharmacol; 1989 Apr; 96(4):807-16. PubMed ID: 2568142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
    Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.
    Striessnig J; Meusburger E; Grabner M; Knaus HG; Glossmann H; Kaiser J; Schölkens B; Becker R; Linz W; Henning R
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):331-40. PubMed ID: 2839780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.
    Garcia ML; King VF; Shevell JL; Slaughter RS; Suarez-Kurtz G; Winquist RJ; Kaczorowski GJ
    J Biol Chem; 1990 Mar; 265(7):3763-71. PubMed ID: 2154487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
    King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
    J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity.
    Schoemaker H; Hicks PE; Langer SZ
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
    Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
    Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialic acid removal modulates the myocardial and vascular activity of calcium channel ligands.
    Werner G; Addicks K; Fricke U; Klaus W; Sarram M; Gielen W
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S77-87. PubMed ID: 1722670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for different receptor sites for the novel cardiotonic S-DPI 201-106, ATX II and veratridine on the cardiac sodium channel.
    Scholtysik G; Quast U; Schaad A
    Eur J Pharmacol; 1986 Jun; 125(1):111-8. PubMed ID: 2426127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
    Robertson MJ; Lumley P
    Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
    Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
    Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.